Findings

What do systematic reviews say?

2,234 questions · 2,325 findings · 216 reviews · Airways

Sort:Best matchNewestHighest certainty Download CSV

No studies found 249 · 10.7%GRADE not reported 107 · 4.6%Very low 276 · 11.9%Low 751 · 32.3%Moderate 718 · 30.9%High 224 · 9.6%

Intervention not reported

HRQoL ‐ CRQ subgrouped by domain (change from baseline; mixed population) ‐ dyspnoea · patients with stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 123 participants
Low

Intervention not reported

HRQoL ‐ CRQ subgrouped by domain (change from baseline; mixed population) ‐ fatigue · patients with stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 123 participants
Low

Intervention not reported

HRQoL ‐ CRQ subgrouped by domain (change from baseline; mixed population) ‐ emotion · patients with stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 123 participants
Low

Intervention not reported

HRQoL ‐ CRQ subgrouped by domain (change from baseline; mixed population) ‐ mastery · patients with stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 123 participants
Low

Intervention not reported

Fat‐free mass index (mixed population) kg/m2 · patients with stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 93 participants
Low

Intervention not reported

Fat‐free mass index (undernourished patients) kg/m2 · patients with stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 62 participants
Low

Intervention not reported

Mid‐arm muscle circumference (mixed population) cm · patients with stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 246 participants
Low

Intervention not reported

Skinfold thickness (mixed measures and mixed population) cm · stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 179 participants
Low

Intervention not reported

Functional exercise capacity ‐ 6‐minute walk test (mixed population) metres · stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 142 participants
Low

Intervention not reported

FEV1 litres and % predicted · stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 228 participants
Low

Intervention not reported

FEV1 litres · stable chronic obstructive pulmonary disease

1 finding from 1 review

Nutritional supplementation for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 76 participants
Low

Inhaled corticosteroids vs placebo

Hospital admissions · patients with acute asthma

ICS may leads to lower hospital admission compared with placebo (low certainty).

1 finding from 1 review

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma 2012 · Cochrane Headline outcomes only
OR 0.44 [0.31, 0.61]
12 studies · 959 participants
Low

Inhaled corticosteroids vs placebo

FEV1 (L) · patients with acute asthma

ICS showed no clear difference in FEV1 at 1 hour compared with placebo (low certainty).

1 finding from 1 review

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma 2012 · Cochrane Headline outcomes only
MD 0.28
4 studies · 248 participants
Low

Inhaled corticosteroids vs placebo

FEV1 · patients with acute asthma

ICS showed no clear difference in FEV1 at 3 to 4 hours compared with placebo (moderate certainty).

1 finding from 1 review

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma 2012 · Cochrane Headline outcomes only
MD 0.15
4 studies · 319 participants
Moderate

Inhaled corticosteroids vs placebo

Nausea and vomiting · patients with acute asthma

ICS showed no clear difference in adverse effects ‐ nausea/vomiting compared with placebo (low certainty).

1 finding from 1 review

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma 2012 · Cochrane Headline outcomes only
OR 0.32 [0.03, 3.18]
1 study · 94 participants
Low

Inhaled corticosteroids vs systemic corticosteroids

Hospital admissions · patients with acute asthma

ICS showed no clear difference in hospital admission compared with systemic corticosteroids (low certainty).

1 finding from 1 review

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma 2012 · Cochrane Headline outcomes only
OR 0.56 [0.25, 1.24]
10 studies · 763 participants
Low

Any ICS plus oral corticosteroid vs oral corticosteroid

Asthma relapse1at 20 to 24 days · predominantly adults with acute asthma following emergency department discharge

Any ICS plus oral corticosteroid showed no clear difference in asthma relapse1at 20 to 24 days compared with oral corticosteroid (high certainty).

1 finding from 1 review

Inhaled steroids for acute asthma following emergency department discharge 2012 · Cochrane Headline outcomes only
OR 0.68 [0.46, 1.02]
3 studies · 909 participants
High

Any ICS plus oral corticosteroid vs oral corticosteroid

Hospital admissions · predominantly adults with acute asthma following emergency department discharge

Any ICS plus oral corticosteroid showed no clear difference in hospital admission compared with oral corticosteroid (moderate certainty).

1 finding from 1 review

Inhaled steroids for acute asthma following emergency department discharge 2012 · Cochrane Headline outcomes only
OR 0.99 [0.39, 2.52]
2 studies · 805 participants
Moderate

Any ICS plus oral corticosteroid vs oral corticosteroid

Hoarseness at 20 to 24 days · predominantly adults with acute asthma following emergency department discharge

Any ICS plus oral corticosteroid showed no clear difference in hoarseness at 20 to 24 days compared with oral corticosteroid (moderate certainty).

1 finding from 1 review

Inhaled steroids for acute asthma following emergency department discharge 2012 · Cochrane Headline outcomes only
OR 0.6 [0.36, 1.01]
2 studies · 596 participants
Moderate

Any ICS vs oral corticosteroid

Asthma relapse1at 16 to 21 days · patients with acute asthma following emergency department discharge

Any ICS showed no clear difference in asthma relapse1at 16 to 21 days compared with oral corticosteroid (moderate certainty).

1 finding from 1 review

Inhaled steroids for acute asthma following emergency department discharge 2012 · Cochrane Headline outcomes only
OR 1.26 [0.8, 1.99]
2 studies · 425 participants
Moderate